Zhai, H., Zhong, W., Yang, X., & Wu, Y. (2015). Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer. Transl Lung Cancer Res.
Chicago ZitierstilZhai, Haoran, Wenzhao Zhong, Xuening Yang, und Yi-Long Wu. "Neoadjuvant and Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Therapy for Lung Cancer." Transl Lung Cancer Res 2015.
MLA ZitierstilZhai, Haoran, Wenzhao Zhong, Xuening Yang, und Yi-Long Wu. "Neoadjuvant and Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Therapy for Lung Cancer." Transl Lung Cancer Res 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.